Exploring Outcomes and Characteristics of Myasthenia Gravis 2 (EXPLORE-MG2)
- Study HIC#:2000026920REG
- Last Updated:02/02/2024
If you have a clinicial diagnosis of myasthenia gravis (MG) you may be eligible to participate in the EXPLORE-MG2 study, which is a multi-center natural history study of myasthenia gravis (MG), a rare autoimmune disease characterized by weakness of the voluntary muscles. The primary purpose of this project is to create a network repository of data and biological samples to help researchers learn more about myasthenia gravis.
Contact Us
For more information about this study, including how to volunteer, contact:
Bailey Sheldon
- Phone Number: 1-203-737-7095
Help Us Discover!
You can help our team find trials you might be eligible for by creating a volunteer profile in MyChart. To get started, create a volunteer profile, or contact helpusdiscover@yale.edu, or call +18779788343 for more information.
Trial Purpose and Description
If you have a clinicial diagnosis of myasthenia gravis (MG) you may be eligible to participate in the EXPLORE-MG2 study, which is a multi-center natural history study of myasthenia gravis (MG), a rare autoimmune disease characterized by weakness of the voluntary muscles. The primary purpose of this project is to create a network repository of data and biological samples to help researchers learn more about myasthenia gravis.
Eligibility Criteria
To pre-qualify for this study, you must:
• Be 18 years of age or older
• Have been diagnosed with Myasthenia Gravis
- Additional criteria will apply
Principal Investigator
- Score: 1
